FFF is now offering AURLUMYN^™ (iloprost) injection

December 5, 2024

FFF Enterprises is excited to announce that it has entered an exclusive partnership with SERB Pharmaceuticals to provide AURLUMYN^™ (iloprost) injection, a prostacyclin mimetic indicated for the treatment of severe frostbite in adults to reduce the risk of digit amputations. ^1,2

Aurlumyn^™ (iloprost) injection is the only FDA-approved treatment option for severe frostbite in the US.

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

• AURLUMYN may cause symptomatic hypotension. Correct hypotension prior to administration of AURLUMYN. Monitor vital signs while administering AURLUMYN.

Adverse Reactions

• Adverse events reported with the use of intravenous (IV) iloprost in patients with frostbite include headache, flushing, palpitations/tachycardia, nausea, vomiting, dizziness, and hypotension.

Visit aurlumyn.com/#ISI for complete Important Safety Information.

To report suspected adverse reactions, contact BTG at 1-877-377-3784 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

1. Click to view full Prescribing Information for AURLUMYN^™ (iloprost) injection

Contact Wow! Customer Care or your FFF Sales Representative to place an order today.

We appreciate your partnership and thank you for trusting FFF to fulfill your critical care pharmaceutical needs.

Together, we are Helping Healthcare Care^®.

Sincerely,
FFF Enterprises

2. Free Next Business Day shipping for orders placed by 12:00 p.m. PT.